rs142354133
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The ENST00000371697.4(ANKRD1):c.347C>T(p.Thr116Met) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000129 in 1,567,716 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. T116T) has been classified as Benign.
Frequency
Consequence
ENST00000371697.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANKRD1 | NM_014391.3 | c.347C>T | p.Thr116Met | missense_variant, splice_region_variant | 4/9 | ENST00000371697.4 | NP_055206.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANKRD1 | ENST00000371697.4 | c.347C>T | p.Thr116Met | missense_variant, splice_region_variant | 4/9 | 1 | NM_014391.3 | ENSP00000360762 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000183 AC: 24AN: 131302Hom.: 0 Cov.: 29
GnomAD3 exomes AF: 0.000146 AC: 36AN: 245818Hom.: 0 AF XY: 0.000150 AC XY: 20AN XY: 133362
GnomAD4 exome AF: 0.000124 AC: 178AN: 1436370Hom.: 0 Cov.: 30 AF XY: 0.000140 AC XY: 100AN XY: 715500
GnomAD4 genome AF: 0.000183 AC: 24AN: 131346Hom.: 0 Cov.: 29 AF XY: 0.000141 AC XY: 9AN XY: 63712
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2020 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 23, 2021 | In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 23572067, 20497191, 19589340, 18273862, 19525294, 32880476) - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Sep 09, 2015 | The p.Thr116Met variant has been identified at low frequency in various populati ons by the Exome Aggregation Consortium (highest in Europeans; 14/65994 chromoso mes; ExAC, http://exac.broadinstitute.org/; dbSNP rs142354133). This variant has been reported in 1 adult with anomalous pulmonary venous return (TAPVR) and ASD (Cinquetti 2008) as well as 1 adult and one affected relative with DCM (Duboscq -Bidot 2009). In vitro functional studies provide some evidence that the p.Thr11 6Met variant may impact the protein (Cinquetti 2008, Duboscq-Bidot 2009), but th ese types of assays may not accurately represent biological function. In summary , the clinical significance of the p.Thr116Met variant is uncertain. - |
ANKRD1-related dilated cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 19, 2023 | This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 116 of the ANKRD1 protein (p.Thr116Met). This variant is present in population databases (rs142354133, gnomAD 0.03%). This missense change has been observed in individual(s) with total anomalous pulmonary venous return (TAPVR) and/or dilated cardiomyopathy (DCM) (PMID: 18273862, 19525294, 32880476). ClinVar contains an entry for this variant (Variation ID: 228439). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on ANKRD1 function (PMID: 18273862, 19525294). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 06, 2023 | The p.T116M variant (also known as c.347C>T), located in coding exon 4 of the ANKRD1 gene, results from a C to T substitution at nucleotide position 347. The threonine at codon 116 is replaced by methionine, an amino acid with some similar properties, and is located in the PEST domain. In one study, this alteration was reported in a proband with total anomalous pulmonary venous return, and functional studies showed an increase in the stability of the protein; however the physiological relevance of this finding is unclear (Cinquetti R et al. Hum Mutat. 2008;29(4):468-74). This alteration was reported in a father and son with dilated cardiomyopathy (DCM) (Duboscq-Bidot L et al. Eur Heart J. 2009;30(17):2128-36), and has been reported in additional DCM cohorts (Verdonschot JAJ et al. Circ Genom Precis Med. 2020 10;13(5):476-487) as well as an exome sequencing cohort not selected for the presence of cardiovascular disease; however, details were limited (Norton N et al. Circ Cardiovasc Genet. 2012 Apr;5(2):167-74). This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at